OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Check out the latest features and columns!
September's Executive Profile features Kevin Ali, CEO of Organon
Senior leaders in pharma, healthcare marketing and communications, and advertising got together to discuss the progress and lingering roadblocks in advancing diversity, equity, and inclusion strategies in the life sciences
Pharm Exec profiles its 2022 Emerging Pharma Leaders
The windfall from COVID-19 vaccines and treatments has shaken up Pharm Exec’s latest listing of the top global biopharma sales producers in record-breaking fashion
September 21, 2022
Lasso and CMI Media Group are the first to successfully leverage IBM Watson's dynamic creative capabilities for healthcare marketing, driving media performance 40% above benchmark.
Brand Institute, the naming agency, is proud to celebrate the 20-year anniversary of the company's expansion into Europe
Award-winning healthcare IT marketing & PR agency to collaborate with leader in data and analytics software solutions and services.
A cookieless future is on the horizon, so marketers across all industries are being forced to rethink their strategies and plan for the future. What does that entail?
September 20, 2022
With more people working from home, employers should rethink how cost-of-living impacts salary negotiations.
Agency officials express associated concerns around clinical trial data reliability and quality.
Rohit Gupta is vice president of analytics strategy and transformation at Beghou Consulting - he works with biopharma leaders on all facets of drug commercialization, from market sizing strategies, to launch planning, to business analytics.
September 16, 2022
Life sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.
September 15, 2022
Life sciences companies a likely targets of these kinds of attacks.